Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Abilita Bio

Abilita Bio
2014 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
3 INVESTORS
Description

Owner and operator of an innovation-driven biotechnology company intended to develop drugs targeting membrane proteins. The company's services mainly focus on discovering and developing therapeutic drugs and technologies to enable discovery and development of drugs targeting membrane proteins including G protein-coupled receptors (GPCRs) and ion channels through the application of its enabled membrane proteins technology platform, enabling clients to have access to tool receptors for antibody discovery and a technical service through the generation of enabled membrane proteins.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abilita Bio’s full profile, request a free trial.

Abilita Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 20-Sep-2016 Completed Startup
3. Grant 01-Jan-2016 00000 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
1. Angel (individual) 01-Jan-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Abilita Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Cancer Institute Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0

Abilita Bio Executive Team (3)

Name Title Board
Seat
Contact
Info
Mauro Mileni Ph.D Founder & Chief Executive Officer
Rosario Billetta Chief Technology Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »